ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696921; 2) Community: the network communities that were significantly associated with the response to NSC 696921; 3) Molecule: the relationships between components within communities and NSC 696921; 4) MDR: the compounds that were significantly associated with the NSC 696921.

NSC Compound Enrichment Correlation
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000871592241209859 0.13968113
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.000871592241209859 0.23120637
NSC 755423 Null 0.000871592241209859 0.29855792
NSC 163062 TRIPTOLIDE 0.000880521445136051 0.39013474
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.000880521445136051 0.11900685
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.000880521445136051 0.10509048
NSC 529108 4-Fluoro-D,L-tryptophan 0.000880521445136051 0.092943239
NSC 631451 Null 0.000880521445136051 -0.0042387195
NSC 652561 Null 0.000880521445136051 0.33391571
NSC 678918 1,6-Phenazinedicarboxamide, N,N'-bis[2-(dimethylamino) ethyl]-, dihydrochloride 0.000880521445136051 0.22038212
Total:170  Current:10    [First] [Prev] [Next] [Last]